Hubei Gedian Humanwell Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Hubei Gedian Humanwell focuses on R&D, production, & sales of fertility regulation drugs & steroidal APIs.
One of their notable products is BUDESONIDE, with a corresponding US DMF Number 34268.
Remarkably, this DMF maintains an Active status since its submission on October 29, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 03, 2022, and payment made on April 21, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II